home / stock / dsnky / dsnky quote
Last: | $30.86 |
---|---|
Change Percent: | -1.64% |
Open: | $31 |
Close: | $30.86 |
High: | $31 |
Low: | $30.38 |
Volume: | 93,235 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$30.86 | $31 | $30.86 | $31 | $30.38 | 93,235 | 04-25-2024 |
$30.5 | $30.16 | $30.5 | $30.65 | $30.16 | 95,252 | 04-24-2024 |
$30.29 | $29.18 | $30.29 | $30.3 | $29.18 | 78,320 | 04-23-2024 |
$30.12 | $30.16 | $30.12 | $30.33 | $30.05 | 119,140 | 04-22-2024 |
$30.18 | $30.38 | $30.18 | $30.43 | $29.9153 | 1,638,146 | 04-19-2024 |
$29.58 | $29.4 | $29.58 | $29.99 | $29.29 | 1,802,438 | 04-18-2024 |
$29.15 | $29 | $29.15 | $29.31 | $28.75 | 543,623 | 04-17-2024 |
$29.48 | $29.1 | $29.48 | $29.62 | $29.1 | 87,615 | 04-16-2024 |
$29.33 | $30.45 | $29.33 | $30.45 | $29.3 | 67,534 | 04-15-2024 |
$29.84 | $30.45 | $29.84 | $30.9 | $29.8 | 41,592 | 04-12-2024 |
$29.772 | $29.64 | $29.772 | $30.2 | $29.45 | 115,332 | 04-11-2024 |
$29.43 | $30 | $29.43 | $30 | $29.33 | 47,611 | 04-10-2024 |
$30.504 | $30.5 | $30.504 | $30.95 | $30.37 | 80,367 | 04-09-2024 |
$30.9 | $30.94 | $30.9 | $31.05 | $30.85 | 35,613 | 04-08-2024 |
$31.15 | $30.89 | $31.15 | $31.35 | $30.89 | 68,439 | 04-05-2024 |
$31.03 | $31.435 | $31.03 | $31.47 | $30.94 | 42,862 | 04-04-2024 |
$31.215 | $31.88 | $31.215 | $31.88 | $31 | 47,305 | 04-03-2024 |
$30.49 | $30.98 | $30.49 | $30.98 | $30.36 | 30,535 | 04-02-2024 |
$30.82 | $30.15 | $30.82 | $31.03 | $30.15 | 74,659 | 04-01-2024 |
$31.81 | $32.43 | $31.81 | $32.43 | $31.74 | 33,797 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
Daiichi Sankyo Co Ltd Sponsored ADR Level 1 Company Name:
DSNKY Stock Symbol:
OTCMKTS Market:
On Friday, the FDA approved Daiichi Sankyo Ltd’s (OTC:DSKYF) (OTC:DSNKY) and AstraZeneca Plc’s (NASDAQ:AZN) Enhertu...
Pfizer Inc (NYSE:PFE) is set to announce its fourth quarter 2023 earnings next week on 30th January. The analysts expect the US pharma giant to re...
Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares are trading lower on Wednesday after the company announced a $125 million amendment to the c...